| 19 June, 2017

Canadian Valeant pharma adds shareholder John Paulson to board

June 19 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals said it appointed hedge fund manager and billionaire investor John Paulson to its board.

Paulson, who heads hedge fund Paulson & Co, is expected to join the board on June 14, the company said on Monday.

Paulson & Co is Valeant's largest shareholder with a 5.68 percent stake as of March 31, according to Reuters data.

(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Saumyadeb Chakrabarty) ((; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 2405; Reuters Messaging: